Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Comparative Effectiveness Research, 10 Years After the ACA: Where Do We Go from Here?
Commonwealth Fund March 12, 2020
Toplines
Comparative effectiveness research can be a powerful tool to bring down the cost of drugs
An increased role for comparative effectiveness research would help U.S. payers lower drug costs and prioritize the most effective medications
Most of us are aware that the United States spends far more on prescription drugs than other high-income countries do. Probably less well known is that Americans also use more drugs and treatments that provide only marginal clinical benefit. So why do people around the world not only spend less, but receive medicines that are more effective?
In part, it’s because most other countries rely on comparative effectiveness research (CER) to...
Today's Sponsors
Today's Sponsor